skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 154  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Biotechnology Industry remove Journal Title: The Financial Times remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Factory to turn out 1m cows a year as China raises steaks in cloning research
Material Type:
Newspaper Article
Add to My Research

Factory to turn out 1m cows a year as China raises steaks in cloning research

The Financial times (London ed.), 2015-11-24

Copyright Financial Times Ltd. 2015. All rights reserved. ;ISSN: 0307-1766

Digital Resources/Online E-Resources

2
Rule changes cause haemorrhage of scientists at leading US medical research institution: USA 1ST EDITION
Material Type:
Newspaper Article
Add to My Research

Rule changes cause haemorrhage of scientists at leading US medical research institution: USA 1ST EDITION

The Financial times (London ed.), 2005-05-19

Copyright Financial Times Ltd. 2005. All rights reserved. ;ISSN: 0307-1766

Digital Resources/Online E-Resources

3
Geron calls time on its embryonic stem cell work
Material Type:
Newspaper Article
Add to My Research

Geron calls time on its embryonic stem cell work

The Financial times (London ed.), 2011-11-16

Copyright Financial Times Ltd. 2011. All rights reserved. ;ISSN: 0307-1766

Digital Resources/Online E-Resources

4
A new era of organ transplants: After decades of false starts, scientists believe that gene editing offers the key to modifying organs from animals for humans to help ease a global shortage that has left thousands on waiting lists. By Clive Cookson [Usa Region]
Material Type:
Newspaper Article
Add to My Research

A new era of organ transplants: After decades of false starts, scientists believe that gene editing offers the key to modifying organs from animals for humans to help ease a global shortage that has left thousands on waiting lists. By Clive Cookson [Usa Region]

The Financial times (London ed.), 2022-02-03

Copyright The Financial Times Limited Feb 3, 2022 ;ISSN: 0307-1766

Digital Resources/Online E-Resources

5
A new era of organ transplants: After decades of false starts, scientists believe that gene editing offers the key to modifying organs from animals for humans to help ease a global shortage that has left thousands on waiting lists
Material Type:
Newspaper Article
Add to My Research

A new era of organ transplants: After decades of false starts, scientists believe that gene editing offers the key to modifying organs from animals for humans to help ease a global shortage that has left thousands on waiting lists

The Financial times (London ed.), 2022-02-03

Copyright The Financial Times Limited Feb 3, 2022 ;ISSN: 0307-1766

Digital Resources/Online E-Resources

6
A new era of organ transplants: After decades of false starts, scientists believe that gene editing offers the key to modifying organs from animals for humans to help ease a global shortage that has left thousands on waiting lists. [Europe Region]
Material Type:
Newspaper Article
Add to My Research

A new era of organ transplants: After decades of false starts, scientists believe that gene editing offers the key to modifying organs from animals for humans to help ease a global shortage that has left thousands on waiting lists. [Europe Region]

The Financial times (London ed.), 2022-02-03

Copyright The Financial Times Limited Feb 3, 2022 ;ISSN: 0307-1766

Digital Resources/Online E-Resources

7
A new era of organ transplants: After decades of false starts, scientists believe that gene editing offers the key to modifying organs from animals for humans to help ease a global shortage that has left thousands on waiting lists. [Asia Region]
Material Type:
Newspaper Article
Add to My Research

A new era of organ transplants: After decades of false starts, scientists believe that gene editing offers the key to modifying organs from animals for humans to help ease a global shortage that has left thousands on waiting lists. [Asia Region]

The Financial times (London ed.), 2022-02-03

Copyright The Financial Times Limited Feb 3, 2022 ;ISSN: 0307-1766

Digital Resources/Online E-Resources

8
Research reality check: Politicians are working on the assumption that there will be a Covid-19 vaccine in 12 to 18 months. But many of the scientists in the field are much less certain and some fear there might never be one. By Hannah Kuchler
Material Type:
Newspaper Article
Add to My Research

Research reality check: Politicians are working on the assumption that there will be a Covid-19 vaccine in 12 to 18 months. But many of the scientists in the field are much less certain and some fear there might never be one. By Hannah Kuchler

The Financial times (London ed.), 2020-05-23

Copyright The Financial Times Limited May 23, 2020 ;ISSN: 0307-1766

Digital Resources/Online E-Resources

9
Research reality check: Politicians are working on the assumption that there will be a Covid-19 vaccine in 12 to 18 months. But many of the scientists in the field are much less certain and some fear there might never be one. By Hannah Kuchler [Usa Region]
Material Type:
Newspaper Article
Add to My Research

Research reality check: Politicians are working on the assumption that there will be a Covid-19 vaccine in 12 to 18 months. But many of the scientists in the field are much less certain and some fear there might never be one. By Hannah Kuchler [Usa Region]

The Financial times (London ed.), 2020-05-23

Copyright The Financial Times Limited May 23, 2020 ;ISSN: 0307-1766

Digital Resources/Online E-Resources

10
Research reality check: Politicians are working on the assumption that there will be a Covid-19 vaccine in 12 to 18 months. But many of the scientists in the field are much less certain and some fear there might never be one. By Hannah Kuchler [Europe Region]
Material Type:
Newspaper Article
Add to My Research

Research reality check: Politicians are working on the assumption that there will be a Covid-19 vaccine in 12 to 18 months. But many of the scientists in the field are much less certain and some fear there might never be one. By Hannah Kuchler [Europe Region]

The Financial times (London ed.), 2020-05-23

Copyright The Financial Times Limited May 23, 2020 ;ISSN: 0307-1766

Digital Resources/Online E-Resources

11
Hunt is on for a cure as more drugs flunk final stages: Treatment Scientists are focusing on new trials that will be an important test of the 'amyloid plaque' hypothesis
Material Type:
Newspaper Article
Add to My Research

Hunt is on for a cure as more drugs flunk final stages: Treatment Scientists are focusing on new trials that will be an important test of the 'amyloid plaque' hypothesis

The Financial times (London ed.), 2018-03-12

Copyright The Financial Times Limited Mar 12, 2018 ;ISSN: 0307-1766

Digital Resources/Online E-Resources

12
Hunt is on for a cure as more drugs flunk final stages: Treatment Scientists are focusing on new trials that will be an important test of the 'amyloid plaque' hypothesis, [Europe Region]
Material Type:
Newspaper Article
Add to My Research

Hunt is on for a cure as more drugs flunk final stages: Treatment Scientists are focusing on new trials that will be an important test of the 'amyloid plaque' hypothesis, [Europe Region]

The Financial times (London ed.), 2018-03-12

Copyright The Financial Times Limited Mar 12, 2018 ;ISSN: 0307-1766

Digital Resources/Online E-Resources

13
Hunt is on for a cure as more drugs flunk final stages: Treatment Scientists are focusing on new trials that will be an important test of the 'amyloid plaque' hypothesis, [Asia Region]
Material Type:
Newspaper Article
Add to My Research

Hunt is on for a cure as more drugs flunk final stages: Treatment Scientists are focusing on new trials that will be an important test of the 'amyloid plaque' hypothesis, [Asia Region]

The Financial times (London ed.), 2018-03-12

Copyright The Financial Times Limited Mar 12, 2018 ;ISSN: 0307-1766

Digital Resources/Online E-Resources

14
Hunt is on for a cure as more drugs flunk final stages: Treatment Scientists are focusing on new trials that will be an important test of the 'amyloid plaque' hypothesis, [Usa Region]
Material Type:
Newspaper Article
Add to My Research

Hunt is on for a cure as more drugs flunk final stages: Treatment Scientists are focusing on new trials that will be an important test of the 'amyloid plaque' hypothesis, [Usa Region]

The Financial times (London ed.), 2018-03-12

Copyright The Financial Times Limited Mar 12, 2018 ;ISSN: 0307-1766

Digital Resources/Online E-Resources

15
Biotech groups urged to focus less on animal tests: Drug research
Material Type:
Newspaper Article
Add to My Research

Biotech groups urged to focus less on animal tests: Drug research

The Financial times (London ed.), 2018-01-18

Copyright The Financial Times Limited Jan 18, 2018 ;ISSN: 0307-1766

Digital Resources/Online E-Resources

16
CAN GENE THERAPY REVOLUTIONISE MEDICINE?: In recent trials, people with rare eye conditions have had their sight restored thanks to gene therapy. Is this the beginning of a transformative era for modern medical science? And what are the costs and dangers of this new approach to finding a cure? David Crow talks to the pioneers and their patients [Usa Region]
Material Type:
Newspaper Article
Add to My Research
17
CAN GENE THERAPY REVOLUTIONISE MEDICINE?: In recent trials, people with rare eye conditions have had their sight restored thanks to gene therapy. Is this the beginning of a transformative era for modern medical science? And what are the costs and dangers of this new approach to finding a cure? David Crow talks to the pioneers and their patients [Asia Region]
Material Type:
Newspaper Article
Add to My Research
18
CAN GENE THERAPY REVOLUTIONISE MEDICINE?: In recent trials, people with rare eye conditions have had their sight restored thanks to gene therapy. Is this the beginning of a transformative era for modern medical science? And what are the costs and dangers of this new approach to finding a cure? David Crow talks to the pioneers and their patients [Europe Region]
Material Type:
Newspaper Article
Add to My Research
19
CAN GENE THERAPY REVOLUTIONISE MEDICINE?: In recent trials, people with rare eye conditions have had their sight restored thanks to gene therapy. Is this the beginning of a transformative era for modern medical science? And what are the costs and dangers of this new approach to finding a cure? David Crow talks to the pioneers and their patients
Material Type:
Newspaper Article
Add to My Research

CAN GENE THERAPY REVOLUTIONISE MEDICINE?: In recent trials, people with rare eye conditions have had their sight restored thanks to gene therapy. Is this the beginning of a transformative era for modern medical science? And what are the costs and dangers of this new approach to finding a cure? David Crow talks to the pioneers and their patients

The Financial times (London ed.), 2017-10-21

Copyright The Financial Times Limited Oct 21, 2017 ;ISSN: 0307-1766

Digital Resources/Online E-Resources

20
Treatments Scientists turn to blood antibodies in drug race [Asia Region]
Material Type:
Newspaper Article
Add to My Research

Treatments Scientists turn to blood antibodies in drug race [Asia Region]

The Financial times (London ed.), 2020-05-14

Copyright The Financial Times Limited May 14, 2020 ;ISSN: 0307-1766

Digital Resources/Online E-Resources

Results 1 - 20 of 154  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2000  (25)
  2. 2000 To 2004  (59)
  3. 2005 To 2009  (22)
  4. 2010 To 2015  (15)
  5. After 2015  (34)
  6. More options open sub menu

Searching Remote Databases, Please Wait